Mayne Pharma Group (MYX) Price & Analysis

Q: How many shares outstanding does Mayne Pharma Group have?

Mayne Pharma Group has 81,245,830 shares outstanding.

Q: What happened to Mayne Pharma Group’s price movement after its last earnings report?

Mayne Pharma Group reported an EPS of -AU$0.253 in its last earnings report, missing expectations of -AU$0.125. Following the earnings report the stock price went up 0.139%.

Compare

34 Followers

MYX Stock Chart & Stats

Day’s Range― - ―

52-Week RangeAU$3.74 - AU$7.31

Previous CloseN/A

Volume149.18K

Average Volume (3M)1.16M

Market Cap

$407.85M

Enterprise ValueN/A

Total Cash (Recent Filing)$124.91M

Total Debt (Recent Filing)AU$39.87M

Price to Earnings (P/E)―

Beta0.20

Next Earnings

Aug 21, 2025

EPS Estimate

<0.01

Last Dividend Ex-Date

Jan 18, 2023

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.25

Shares Outstanding81,245,830

10 Day Avg. Volume1,198,766

30 Day Avg. Volume1,158,107

Financial Highlights & Ratios

PEG Ratio-0.18

Price to Book (P/B)1.64

Price to Sales (P/S)0.00

P/FCF Ratio-52.22

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

$7.40

Price Target Upside47.34% Upside

Rating ConsensusHold

Number of Analyst Covering1

Mayne Pharma Group News

PremiumCompany Announcements

Mitsubishi UFJ Financial Group Acquires Substantial Holding in Mayne Pharma

3d ago

PremiumCompany Announcements

Mayne Pharma’s Scheme Meeting to Proceed Amidst Cosette’s Termination Notice

4d ago

PremiumCompany Announcements

Mayne Pharma Challenges Cosette’s Termination Notice of Scheme Implementation Deed

5d ago

PremiumCompany Announcements

Mayne Pharma Updates on Cosette Scheme and FDA Clearance

5d ago

PremiumCompany Announcements

Goldman Sachs Increases Stake in Mayne Pharma Group

5d ago

PremiumCompany Announcements

UBS Increases Stake in Mayne Pharma Group

7d ago

PremiumCompany Announcements

Mayne Pharma Files Legal Complaint Against TherapeuticsMD

7d ago

PremiumCompany Announcements

UBS Reduces Stake in Mayne Pharma Group

13d ago

See All AU:MYX News

See All News >

Financials

Income Statement >

Options Prices

Currently, No data available

---

Ownership Overview

0.10% Insiders

3.18%

Mutual Funds

<0.01% Other Institutional Investors

94.69% Public Companies and

Individual Investors

Detailed Ownership Overview >

MYX FAQ

What was Mayne Pharma Group’s price range in the past 12 months?

Mayne Pharma Group lowest share price was AU$3.74 and its highest was AU$7.31 in the past 12 months.

What is Mayne Pharma Group’s market cap?

Mayne Pharma Group’s market cap is $407.85M.

When is Mayne Pharma Group’s upcoming earnings report date?

Mayne Pharma Group’s upcoming earnings report date is Aug 21, 2025 which is in 73 days.

How were Mayne Pharma Group’s earnings last quarter?

Mayne Pharma Group released its earnings results on Feb 25, 2025. The company reported -AU$0.253 earnings per share for the quarter, missing the consensus estimate of -AU$0.125 by -AU$0.128.

Is Mayne Pharma Group overvalued?

According to Wall Street analysts Mayne Pharma Group’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Mayne Pharma Group pay dividends?

Mayne Pharma Group pays a Notavailable dividend of AU$0.027 which represents an annual dividend yield of N/A. See more information on Mayne Pharma Group dividends here

What is Mayne Pharma Group’s EPS estimate?

Mayne Pharma Group’s EPS estimate is <0.01.

How many shares outstanding does Mayne Pharma Group have?

Mayne Pharma Group has 81,245,830 shares outstanding.

What happened to Mayne Pharma Group’s price movement after its last earnings report?

Mayne Pharma Group reported an EPS of -AU$0.253 in its last earnings report, missing expectations of -AU$0.125. Following the earnings report the stock price went up 0.139%.

Which hedge fund is a major shareholder of Mayne Pharma Group?

Currently, no hedge funds are holding shares in AU:MYX

Mayne Pharma Group Stock Smart Score

Neutral

Fundamentals

Return on Equity

-23.92%

Trailing 12-Months

Asset Growth

-11.07%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Mayne Pharma Group

Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe and Asia. The company operates through four segments: Metrics Contract Services, International, Branded Products, and Portfolio Products. It provides oral drug delivery systems; and contract pharmaceutical development, manufacturing, and analytical services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.

MYX Company Deck

MYX Earnings Call

Q2 2025

0:00 / 0:00

MYX Stock 12 Month Forecast

Average Price Target

AU$7.40

▲(47.34%Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"2":"AU$2","5":"AU$5","8":"AU$8","3.5":"AU$3.5","6.5":"AU$6.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":7.3930586930848,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">AU$7.39</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":7.3964724496,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">AU$7.40</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":7.3930586930848,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">AU$7.39</span>\n  </div></div>","useHTML":true}}],"tickPositions":[2,3.5,5,6.5,8],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Feb<br/>2024","6":"Aug<br/>2024","9":"Dec<br/>2024","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7,7.030235284083446,7.060470568166893,7.090705852250339,7.1209411363337844,7.151176420417231,7.181411704500677,7.211646988584123,7.241882272667569,7.272117556751016,7.302352840834462,7.3325881249179075,7.362823409001354,{"y":7.3930586930848,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7,7.030497880738461,7.060995761476923,7.091493642215385,7.121991522953846,7.152489403692308,7.182987284430769,7.213485165169231,7.243983045907692,7.274480926646154,7.304978807384615,7.335476688123077,7.365974568861539,{"y":7.3964724496,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7,7.030235284083446,7.060470568166893,7.090705852250339,7.1209411363337844,7.151176420417231,7.181411704500677,7.211646988584123,7.241882272667569,7.272117556751016,7.302352840834462,7.3325881249179075,7.362823409001354,{"y":7.3930586930848,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":3.27,"date":1696118400000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":3.54,"date":1698796800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":5.48,"date":1701388800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":5.28,"date":1706745600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.8,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.64,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.22,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.11,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.43,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.36,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.57,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.28,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >